Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.

导出 OA

翻译打印收藏纠错

第一作者： J P,Sevilla

第一单位： Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115; jsevilla@gmail.com.;Life Sciences Group, Data for Decisions, LLC, Waltham, MA 02451.

作者： J P,Sevilla ^[1] ; David E,Bloom ^[2] ; Daniel,Cadarette ^[2] ; Mark,Jit ^[3] ; Marc,Lipsitch ^[4]

作者单位： Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115; jsevilla@gmail.com.;Life Sciences Group, Data for Decisions, LLC, Waltham, MA 02451. ^[1] Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115. ^[2] Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.;Modeling and Economics Unit, Public Health England, London NW9 5EQ, United Kingdom. ^[3] Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA 02115.;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115.;Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115. ^[4]

关键词 antimicrobial resistance economic evaluation health technology assessment immunization vaccines